Phaseline

Targets › ATPV1A1

ATPV1A1: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 4; Infectious disease; next expected readout Jun 2027.

Open in Phaseline: the race on ATPV1A1, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
The First Affiliated Hospital with Nanjing Medical UniversityVAB-7
Proton pump inhibitor (vonoprazan) combined with beta-lactam antibiotic (amoxicillin) and
ATPV1A1Phase 4Helicobacter PyloriJun 2027

Conditions

Helicobacter Pylori (1)

Modalities

small molecule (1)

Companies

The First Affiliated Hospital with Nanjing Medical University (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.